Key result
Glucose lowering in patients admitted with acute myocardial infarction shows no clear evidence of additional mortality benefit over routine care.
Why the study?
Does glucose lowering reduce mortality in patients admitted to hospital with acute myocardial infarction?
Does glucose lowering reduce mortality in patients admitted to hospital with acute myocardial infarction?
Current clinical trial data is inconclusive regarding the mortality benefit of glucose lowering beyond routine care in patients with acute myocardial infarction.
May not warrant intensified glucose control for mortality reduction in AMI; leaves open targeted trials in hyperglycemic subgroups.
This review summarises the available clinical trials data investigating the effects of glucose lowering on mortality in patients admitted to hospital with acute myocardial infarction. The results of these studies are inconclusive with no clear evidence that this intervention has additional benefit over and above routine care.
No takes yet. Share an insight, caveat, or question.
G. D. Braatvedt (2008) studied this question. Glucose lowering in patients admitted with acute myocardial infarction shows no clear evidence of additional mortality benefit over routine care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: